SYMJEPI keeps the confidence to handle allergic emergencies
close at hand, wherever you are
SYMJEPI contains the same medicine as in the most widely used
epinephrine auto-injectors (EAIs), and it is packaged in a compact,
easy-to-carry, and ready-to-use device.*
SYMJEPI keeps the confidence to handle allergic emergencies close at hand, wherever you are
SYMJEPI contains the same medicine as in the most widely used epinephrine auto-injectors (EAIs), and it is packaged in a compact, easy-to-carry, and ready-to-use device.*
The SYMJEPI Injection device is smaller than the most widely used EAI so it fits easily in your pocket or purse when you're on the go.
Each device delivers 1 dose of epinephrine in an emergency allergic reaction situation. The window gives you confidence that the medicine has been delivered.†
Some medicine may be left in the device, but the correct dose has been injected if the plunger has been pushed all the way down and the window is at least partially blocked.
SYMJEPI 0.3 mg is for patients who weigh approximately 66 lb (30 kg) or more
SYMJEPI 0.15 mg is for patients who weigh 33 lb to 66 lb (15 kg to 30 kg)
SYMJEPI is indicated in the emergency treatment of allergic reactions (Type 1) including anaphylaxis to stinging insects (e.g., order Hymenoptera, which include bees, wasps, hornets, yellow jackets and fire ants) and biting insects (e.g., triatoma, mosquitoes), allergen immunotherapy, foods, drugs, diagnostic testing substances (e.g., radiocontrast media) and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis.
Warnings and Precautions
SYMJEPI may cause serious side effects.
Common side effects of SYMJEPI include:
These side effects may go away with rest. Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of SYMJEPI. For more information, ask your healthcare provider or pharmacist.
Please see full Prescribing Information for SYMJEPI.
To report SUSPECTED ADVERSE REACTIONS, contact Adamis Pharmaceuticals Corporation at
References: 1. FDA drug shortages. US Food & Drug Administration website. https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Epinephrine%20Injection,%20Auto-Injector&st=c&tab=tabs-1#. Accessed October 8, 2020. 2. Stecher D, Bulloch B, Sales J, Schaefer C, Keahey L. Epinephrine auto-injectors: is needle length adequate for delivery of epinephrine intramuscularly? Pediatrics. 2009;124(1):65-70.
Warnings and Precautions